Simpson Jennifer K.
- SEC CIK
- 0001545253
No open-market purchases or sales filed in the past year.
Current role at each company
- PBLA Panbela Therapeutics, Inc.President and CEOas of Oct 3, 2024
- LADX LadRx CorpDirectoras of Jan 29, 2024
- EGRX Eagle Pharmaceuticals, Inc.Directoras of Mar 9, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Simpson Jennifer K. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
PBLA Panbela Therapeutics, Inc.
President and CEO2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 1, 2023 (view filing) | Jan 30 | 2 days | Simpson Jennifer K.President and CEO | PPurchase | +4.44K | – | – | +129.8%7.87K after | |
| Feb 1, 2023 (view filing) | Jan 30 | 2 days | Simpson Jennifer K.President and CEO | PPurchase | +8.89K | $0.00 | $0 | –8.89K after | Derivative |